ALKSV — Alkermes Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeLarge CapNeutral

Annual income statement for Alkermes, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2018 December 31st	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	1,094	1,171	1,039	1,174	1,112
Cost of Revenue
Gross Profit	918	991	860	976	894
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	1,193	1,346	1,151	1,206	1,254
Operating Profit	-99.1	-175	-112	-32.3	-142
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-127	-197	-96.5	-39.3	-167
Provision for Income Taxes
Net Income After Taxes	-139	-197	-111	-48.2	-158
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	-139	-197	-111	-48.2	-158
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-139	-197	-111	-48.2	-158
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-0.898	-1.2	-0.698	-0.287	-0.968